MACA
Moringa Acquisition Corp - Ordinary Shares - Class A

93
Mkt Cap
$6.97M
Volume
0.00
52W High
$63.45
52W Low
$2.13
PE Ratio
-0.10
MACA Fundamentals
Price
$2.37
Prev Close
$2.23
Open
$2.28
50D MA
$3.31
Beta
0.96
Avg. Volume
98,086.87
EPS (Annual)
-$395.36
P/B
1.08
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Moringa Acquisition Corp to take Silexion public via merger
Moringa Acquisition Corp to take Silexion public via merger...
SeekingAlpha.com: All News·2y ago
News Placeholder
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Silexion's first generation product, Loder , successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors an oncogene believed to be...
Globe Newswire·2y ago

Latest MACA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.